ARKRAY Europe, B.V.

What ARKRAY Europe, B.V. does

ARKRAY Europe, B.V. is the European regional subsidiary of Japanese medical device manufacturer ARKRAY, Inc. (Kyoto, publicly traded on the Tokyo Stock Exchange). Established in 2004 and headquartered in Amstelveen, Netherlands, ARKRAY Europe operates as the holding entity for wholly-owned sales and manufacturing operations across 8 European countries (Netherlands, Belgium, Italy, Spain, Portugal, UK, Ireland, plus Poland distribution via Color Trading Sp. z o. o.). Following a strategic shift in December 2021, the company transitioned from a distributor-led model to direct sales, opening five sales offices and a manufacturing facility in Swords, Dublin (ARKRAY Ireland Limited) producing test reagents for the European market.

The company's core product portfolio spans clinical diagnostic instrumentation: ADAMS HbA1c analyzers using HPLC method (the gold standard for glycohemoglobin measurement), AUTION MAX AX-4060 fully-automated urine chemistry analyzers and AUTION EYE AI-4510 urine sediment analyzers with flow cell digital imaging, D-Concept and SPOTCHEM dry chemistry clinical analyzers, and Glucocard blood glucose meters for self-monitoring. The company also offers cloud-based services (AUTION EYE Smart Assist remote sediment classification, SillHa Connect oral wellness), veterinary diagnostics under the thinka brand, lactate testing for sports facilities, rapid malaria test kits (Parahit), and functional food materials (AG Herb MIX, Satonaceil). Proprietary technology pillars include HPLC reversed-phase cation exchange chromatography, flow cell digital imaging with AI classification, and dry chemistry reagent technology.

ARKRAY Europe generates revenue through hardware sales of diagnostic instruments paired with recurring reagent and consumable sales (test strips for AUTION analyzers, glucose test strips for Glucocard meters) to hospital laboratories, clinics, diabetes patients, veterinary practices, and sports facilities. Pricing follows a B2B enterprise sales motion with multi-year contracts negotiated through direct sales representatives, supplemented by unit-pricing consumer channels for self-monitoring blood glucose products. Customer support includes maintenance services and academic affairs activities across the 8-country footprint, with approximately 50 European employees supporting the operation as of November 2021.

Name

ARKRAY Europe, B.V.

Legal name

ARKRAY Europe, B.V.

Website

https://arkray.eu

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

ARKRAY Europe, B.V. is the Netherlands-based European subsidiary of Japanese IVD manufacturer ARKRAY, Inc., selling clinical diagnostic analyzers (HbA1c, urinalysis, dry chemistry) plus blood glucose meters and reagents to hospitals, laboratories, clinics, and patients across 8 European countries via direct sales offices and Irish reagent manufacturing.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Equipment

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industries

Urinalysis & Routine Screening Diagnostics (HLAHAAAG), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• Clinical diagnostic equipment
• Glycohemoglobin analyzers
• Urine analyzers
• Blood glucose meters
• Medical diagnostic reagents

Headquarters

HQ city

AMSTELVEEN

HQ country

Netherlands

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain

Revenue model

1. Clinical Testing Instruments and Diagnostic Reagents: Sales of medical diagnostic instruments (glycohemoglobin analyzers, urine analyzers, biochemistry analyzers) and associated diagnostic reagents and test strips for healthcare facilities including hospitals, clinics, and laboratories.
2. Self-Monitoring Blood Glucose Systems: Sales of blood glucose meters, test strips, and lancing devices for diabetes patients to self-monitor blood glucose levels at home.
3. Functional Food Materials: Development and sales of functional food materials including AG Herb MIX and Satonaceil with anti-glycation properties, backed by clinical trial evidence.
4. Test Reagents Manufacturing and Distribution: Manufacturing of test reagents and product distribution from ARKRAY Ireland Limited manufacturing base for the European market.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

ARKRAY Europe, B.V. manufactures and sells clinical diagnostic testing systems for diabetes, urinalysis, and biochemistry testing across European markets. Core offerings include HbA1c glycohemoglobin analyzers using HPLC methodology, fully automated urine analyzers (AUTION MAX AX-4060) and urine sediment analyzers (AUTION EYE AI-4510) with digital imaging, dry chemistry clinical analyzers, blood glucose self-monitoring meters (Glucocard series), and associated diagnostic reagents and test strips. The company also provides oral wellness systems (SillHa) and veterinary diagnostic products under the thinka brand.

Product overview

ARKRAY provides a comprehensive portfolio of clinical diagnostic systems covering diabetes testing, urinalysis, and biochemistry testing. The core product lines include the ADAMS A1c glycohemoglobin analyzers (HA-8190V, HA-8180T) using HPLC technology for precise HbA1c measurement; the AUTION urine analysis systems including the fully-automated AUTION MAX AX-4060 and the AUTION EYE AI-4510 urine sediment analyzer with digital imaging; the Glucocard blood glucose meter family (W, S, S onyx) for patient self-monitoring; and the D-Concept dry chemistry analyzers for clinical chemistry testing. Supporting services include the AUTION EYE Smart Assist remote classification service and SillHa/SillHa Connect oral wellness system. ARKRAY also develops functional food materials (AG Herb MIX, Satonaceil) leveraging anti-glycation expertise, and serves veterinary markets with thinka-branded products.

Differentiator

Problem solved

Functional benefit

Brands

• ADAMS: Glycohemoglobin analyzers for diabetes testing
• AUTION
• Glucocard
• SPOTCHEM
• SillHa
• thinka
• Parahit
• ARKRAY 4U (ARKRAY FOR YOU)

Products and services

• ADAMS A1c HA-8190V

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Color Trading Sp. z o. o.minorChannel Partner/ Reseller/ Distributor · 1 December 2021Color Trading Sp. z o. o. handles sales management in Poland for ARKRAY products, continuing distribution operations in that specific market while ARKRAY operates direct sales in other European countries.
• Boditech Med Inc.minorStrategic or Co-development PartnerKorean manufacturer of clinical test instruments and reagents with capital alliance relationship established May 2013 for potential strategic collaboration in diagnostic market.
• JICA (Japan International Cooperation Agency)coreStrategic or Co-development PartnerJapanese government's African Health Initiative where ARKRAY participates by providing The Lab 004 blood testing device designed for CKD and liver disease testing in Sub-Saharan Africa environments with limited infrastructure.
• Kyoto UniversitycoreStrategic or Co-development PartnerJoint research partnership for early detection of pancreatic cancer using microRNA blood testing technology, announced August 28, 2024, working with 14 facilities including Kyoto University.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Emerging players

• EKF Diagnostics: EKF Diagnostics provides point-of-care HbA1c (QuikRead go) and hemoglobin analyzers, overlapping with ARKRAY's pocket-sized HbA1c and diabetes-monitoring offerings in smaller clinics.
• Nova Biomedical: Nova Biomedical manufactures StatStrip glucose and lactate meters used in hospital point-of-care settings, competing with ARKRAY's Lactate Pro and Glucocard product lines.

Broad incumbents

• Siemens Healthineers: Siemens Healthineers competes with ARKRAY in clinical chemistry (Atellica/ADVIA Centaur) and urinalysis (Clinitek), serving the same European hospital and reference-lab customers at vastly larger scale.
• Beckman Coulter: Beckman Coulter offers the iQ200 urine sediment analyzer and a broad clinical-chemistry portfolio, directly competing with ARKRAY's AUTION line in mid- and large-sized hospital labs.
• Abbott Diagnostics: Abbott is the global leader in blood glucose self-monitoring (FreeStyle Libre) and a major clinical-chemistry incumbent, overlapping with ARKRAY's Glucocard and dry-chemistry lines.
• Roche Diagnostics: Roche is a global IVD incumbent with urinalysis (Cobas u), clinical chemistry, and HbA1c offerings that compete across ARKRAY's full European portfolio at much greater scale.

Direct peers

• 77 Elektronika: 77 Elektronika is a Hungarian urinalysis specialist offering automated urine analyzers and strips, competing directly with ARKRAY's AUTION MAX across European clinical labs.
• Bio-Rad Laboratories: Bio-Rad is the closest direct peer to ARKRAY in HPLC-based HbA1c testing through its Variant II analyzer family, competing head-to-head in diabetes monitoring reference labs across Europe.
• Sysmex Corporation: Sysmex is a Japan-based diagnostics peer with overlapping urinalysis (UF-series) and hematology product lines and a comparable focus on workflow automation for clinical laboratories.
• Trinity Biotech: Trinity Biotech is a focused HbA1c analyzer competitor (Premier, Ultra2) targeting similar small-to-mid hospital and clinical-lab customers in Europe with HPLC-based technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/arkray-europe-b.v.

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARKRAY Europe, B.V.